Bingen, Germany

Brigit Jung

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Gmbh. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brigit Jung - Innovator in Pharmaceutical Chemistry

Introduction

Brigit Jung is a notable inventor based in Bingen, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of amino acid derivatives. Her work has implications for the treatment of various medical conditions, showcasing her innovative spirit and dedication to advancing science.

Latest Patents

Brigit Jung holds a patent for "Amino acid derivatives, processes for preparing them and pharmaceutical." This invention relates to new amino acid derivatives of a specific general formula and their pharmaceutically acceptable salts. The new compounds are valuable neurokinin (tachykinin)-antagonists, which can play a crucial role in therapeutic applications.

Career Highlights

Brigit Jung is associated with Boehringer Ingelheim GmbH, a leading global pharmaceutical company. Her work at the company has allowed her to focus on innovative research and development in the pharmaceutical sector. With her expertise, she has contributed to the advancement of new therapeutic agents.

Collaborations

Brigit has collaborated with esteemed colleagues such as Franz Esser and Gerd Schnorrenberg. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Brigit Jung's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a leading inventor in the industry. Her work continues to inspire advancements in medical science and therapeutic development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…